期刊文献+

伐昔洛韦联合匹多莫德治疗小儿水痘的疗效观察 被引量:4

伐昔洛韦联合匹多莫德治疗小儿水痘的疗效观察
下载PDF
导出
摘要 目的:探讨伐昔洛韦联合匹多莫德治疗小儿水痘的临床疗效。方法:将120例水痘患儿随机分两组,治疗组及对照组各60例,治疗组伐昔洛韦联合匹多莫德治疗、治疗组用伐昔洛韦治疗。两组均计数退热时间及皮疹结痂时间,同时观察药物的不良反应。结果:治疗组平均退热时间2.51±0.42天,明显少于对照组3.0±0.33天,P<0.05;皮疹结痂时间,治疗组2.99±0.27天,明显少于对照组3.45±0.311天,P<0.05。两组药物治疗过程中无明显不良反应。结论:匹多莫德联合伐昔洛韦治疗带状疱疹比单用伐昔洛韦治疗带状疱疹起效更快、疗程更短、疗效更好。 Observation on the Curative Effect of Pidotimod Combined with Valaciclovir on varicella in children Methods: 120 children with varicella were divided in two groups, experime - ntal group and control group. The children of experimental group were treated with Pidotimod Combined with Valaciclovir; and those of control group were treated with Valaciclovir. The time of fever relieving and scabbing of the patients from two g - roups was observed separately. Results:The time of fever relieving in experimentalgroup was 2.51±0. 42d,and it was shorter than that of the control group 3.0±0. 33d(P 〈0. 05) ; the time of scabbing in experimental group was 2. 99±0. 27d, andit was shorter than that of the control group 3.45±0. 31d( P 〈 0. 05). The side - effectof ganciclovir and virazole was not serious. Conclusion : Pidoti- mod Combined with Valaciclovir is more effecti- ve than Valaciclovir in the treatment of varicella.
作者 黎碧婵
出处 《中国社区医师(医学专业)》 2011年第18期136-137,共2页
关键词 伐昔洛韦 匹多莫德 水痘水痘-带状疱疹病毒 小儿 Ganciclovir Virazole Varicella Varicella - zoster virus Child
  • 相关文献

参考文献4

二级参考文献20

  • 1俞蕙,段恕诚,朱启容,李月芳.水痘的流行病学及临床特点[J].上海预防医学,1998,10(1):26-28. 被引量:25
  • 2葛蒙梁,金祖余.抗水痘-带状疱疹病毒药物研究进展[J].国外医学(皮肤性病学分册),1996,22(6):344-348. 被引量:18
  • 3徐学瑛 李元 等.一个改进的体液免疫测定方法-溶血素测定法[J].药学学报,1979,14(7):443-443.
  • 4孙艳 李涛 徐国梅.万乃洛韦治疗带状疱疹200例疗效观察[J].中华皮肤科杂志,2000,33(1):66-66.
  • 5Coppi G, Falcone A, Manzardo S.Protective effects of pidotimod against experimental bacterial infections in mice[J]. Arzneimittelforsch, 1994; 44: 1417-21
  • 6Dianzani C, Colangelo D, Tonso E, Guidotto S, Viano I. In vivo antiviral effects of pidotimod[J]. Arzneimittelforsch,1994; 44: 1431-3
  • 7Han CW, Imamura M, Hashino S, Zhu X, Tanaka J, Imai K, et al. Differential effects of the immunosuppressants cyclosporine A, FK506 and KW2210 on cytoking gene expression[J]. Bone Marrow Transplant,1995;15:733-9
  • 8Tan HR, Dong Q, Cao LZ, Baishanbo A, Li JM. The effect of immune-potentiating action and expressing lymphocyte factor of pidotimod[J]. J Beijing Med Univ,1999;31:38-41
  • 9Migliorati G, Nicoletti I, Riccardi C. Immunomodulating activity of pidotimod[J]. Arzneimittelforsch,1994; 44: 1421-4
  • 10An LF, Shan SM, Yu SQ. Pidotimod[J]. Chin J New Drugs,1997; 6: 110-1

共引文献69

同被引文献42

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部